期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 51, 期 18, 页码 5494-5497出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm8006068
关键词
-
A biosynthetic medicinal chemistry approach was applied to the optimization of the natural product Hsp90 inhibitor macbecin. By genetic engineering, mutant, have been created to produce novel macbecin analogues including a nonquinone compound (5) that has significantly improved binding affinity to Hsp90 (K-d 3 nM vs 240 nM for macbecin) and reduced toxicity (MTD >= 250 mg/kg). Structural flexibility may contribute to the preorganization of 5 to exist in solution in the Hsp90-bound conformation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据